Nobel Prize, immunology
Antiviral Immunotherapy Comes of Age
Antiviral Immunotherapy Comes of Age
Lucas Laursen | Dec 4, 2017
T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 
Breakthrough Prizes Recognize Geneticists, Big Bang Researchers
Breakthrough Prizes Recognize Geneticists, Big Bang Researchers
Catherine Offord | Dec 3, 2017
Among this year’s winners are a geneticist who revealed how plants respond to shade and a group of physicists who mapped the universe’s background radiation.
Immune System Targets Diverse Viruses Using the Same Small Peptide
Immune System Targets Diverse Viruses Using the Same Small Peptide
Catherine Offord | Dec 1, 2017
A single receptor on natural killer cells recognizes an amino acid sequence conserved across Zika, dengue, and related pathogens.
Meet the Press, 1967
Meet the Press, 1967
Kerry Grens | Dec 1, 2017
Fifty years ago, Arthur Kornberg announced to reporters that his team had synthesized functional DNA.
European Research Council Founder, Molecular Biologist Dies
European Research Council Founder, Molecular Biologist Dies
Catherine Offord | Nov 20, 2017
Fotis Kafatos, a Greek researcher famous for his work on malaria, has died at age 77.
Researchers Build a Cancer Immunotherapy Without Immune Cells
Researchers Build a Cancer Immunotherapy Without Immune Cells
Abby Olena | Nov 13, 2017
A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro. 
Pioneer of Crystallography Dies
Pioneer of Crystallography Dies
Katarina Zimmer | Oct 27, 2017
Isabella Karle has passed away at age 95. 
FDA Approves Second CAR T-Cell Therapy
FDA Approves Second CAR T-Cell Therapy
Ashley P. Taylor | Oct 19, 2017
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 
Compound Found in Red Wine Boosts Immune Cell Function
Compound Found in Red Wine Boosts Immune Cell Function
Catherine Offord | Oct 16, 2017
At low doses, resveratrol enhanced human T-cell activity in vitro, while at high doses it interfered with cell signaling. 
Cancers Relapse by Feeding Off Immune Signals
Cancers Relapse by Feeding Off Immune Signals
Shawna Williams | Oct 16, 2017
In mice, the tumor cells are able to thwart the immune response that would kill them—but immunotherapy prevented the return of melanoma.